GPhA urges state governments to increase access to generics
SGLT2 Inhibitors May Have Clinical Benefits For Patients with Diabetes After Myocardial Infarction | ASHP Midyear
Research found that SGLT2 inhibitors were associated with a lower risk of major cardiovascular events or hospitalization for heart failure.
Looking to the Future of Independent Pharmacy
Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.
In A Warming World, Climate-Resilient Health Care Delivery Is Key | ASHP Midyear
Pharmacists can influence institutional-level climate change-related policies to ensure continued health care delivery.
Podcast: Pharmacy Financing With First Financial Bank
Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.
DES Model Successfully Simulated MASH Diagnosis | ASHP Midyear
Researchers observed the use of a discrete event simulation using non-invasive tests for patients with nonalcoholic steatohepatitis.
Assessing Improvements to Reduce Insulin-Related Hypoglycemic Events | ASHP Midyear
Medication alerts, nurse education, and pharmacist interventions led to lower hypoglycemic events every year after they were implemented.
